Author
Listed:
- Tae-Eun Park
(Wyss Institute for Biologically Inspired Engineering at Harvard University
Ulsan National Institute of Science and Technology (UNIST))
- Nur Mustafaoglu
(Wyss Institute for Biologically Inspired Engineering at Harvard University)
- Anna Herland
(Wyss Institute for Biologically Inspired Engineering at Harvard University
KTH Royal Institute of Technology
Karolinska Institute)
- Ryan Hasselkus
(Wyss Institute for Biologically Inspired Engineering at Harvard University)
- Robert Mannix
(Wyss Institute for Biologically Inspired Engineering at Harvard University
Boston Children’s Hospital and Harvard Medical School)
- Edward A. FitzGerald
(Wyss Institute for Biologically Inspired Engineering at Harvard University)
- Rachelle Prantil-Baun
(Wyss Institute for Biologically Inspired Engineering at Harvard University)
- Alexander Watters
(Wyss Institute for Biologically Inspired Engineering at Harvard University)
- Olivier Henry
(Wyss Institute for Biologically Inspired Engineering at Harvard University)
- Maximilian Benz
(Wyss Institute for Biologically Inspired Engineering at Harvard University)
- Henry Sanchez
(Wyss Institute for Biologically Inspired Engineering at Harvard University)
- Heather J. McCrea
(Boston Children’s Hospital and Harvard Medical School)
- Liliana Christova Goumnerova
(Boston Children’s Hospital and Harvard Medical School)
- Hannah W. Song
(University of Wisconsin-Madison)
- Sean P. Palecek
(University of Wisconsin-Madison)
- Eric Shusta
(University of Wisconsin-Madison)
- Donald E. Ingber
(Wyss Institute for Biologically Inspired Engineering at Harvard University
Harvard University
Boston Children’s Hospital and Harvard Medical School)
Abstract
The high selectivity of the human blood-brain barrier (BBB) restricts delivery of many pharmaceuticals and therapeutic antibodies to the central nervous system. Here, we describe an in vitro microfluidic organ-on-a-chip BBB model lined by induced pluripotent stem cell-derived human brain microvascular endothelium interfaced with primary human brain astrocytes and pericytes that recapitulates the high level of barrier function of the in vivo human BBB for at least one week in culture. The endothelium expresses high levels of tight junction proteins and functional efflux pumps, and it displays selective transcytosis of peptides and antibodies previously observed in vivo. Increased barrier functionality was accomplished using a developmentally-inspired induction protocol that includes a period of differentiation under hypoxic conditions. This enhanced BBB Chip may therefore represent a new in vitro tool for development and validation of delivery systems that transport drugs and therapeutic antibodies across the human BBB.
Suggested Citation
Tae-Eun Park & Nur Mustafaoglu & Anna Herland & Ryan Hasselkus & Robert Mannix & Edward A. FitzGerald & Rachelle Prantil-Baun & Alexander Watters & Olivier Henry & Maximilian Benz & Henry Sanchez & He, 2019.
"Hypoxia-enhanced Blood-Brain Barrier Chip recapitulates human barrier function and shuttling of drugs and antibodies,"
Nature Communications, Nature, vol. 10(1), pages 1-12, December.
Handle:
RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10588-0
DOI: 10.1038/s41467-019-10588-0
Download full text from publisher
Citations
Citations are extracted by the
CitEc Project, subscribe to its
RSS feed for this item.
Cited by:
- Vicky Chou & Richard V. Pearse & Aimee J. Aylward & Nancy Ashour & Mariko Taga & Gizem Terzioglu & Masashi Fujita & Seeley B. Fancher & Alina Sigalov & Courtney R. Benoit & Hyo Lee & Matti Lam & Nicho, 2023.
"INPP5D regulates inflammasome activation in human microglia,"
Nature Communications, Nature, vol. 14(1), pages 1-23, December.
- Iosif Pediaditakis & Konstantia R. Kodella & Dimitris V. Manatakis & Christopher Y. Le & Chris D. Hinojosa & William Tien-Street & Elias S. Manolakos & Kostas Vekrellis & Geraldine A. Hamilton & Lorna, 2021.
"Modeling alpha-synuclein pathology in a human brain-chip to assess blood-brain barrier disruption,"
Nature Communications, Nature, vol. 12(1), pages 1-17, December.
- Huan Chen & Ting Li & Zhiyong Liu & Shuwan Tang & Jintao Tong & Yingfang Tao & Zinan Zhao & Nan Li & Chun Mao & Jian Shen & Mimi Wan, 2023.
"A nitric-oxide driven chemotactic nanomotor for enhanced immunotherapy of glioblastoma,"
Nature Communications, Nature, vol. 14(1), pages 1-21, December.
Corrections
All material on this site has been provided by the respective publishers and authors. You can help correct errors and omissions. When requesting a correction, please mention this item's handle: RePEc:nat:natcom:v:10:y:2019:i:1:d:10.1038_s41467-019-10588-0. See general information about how to correct material in RePEc.
If you have authored this item and are not yet registered with RePEc, we encourage you to do it here. This allows to link your profile to this item. It also allows you to accept potential citations to this item that we are uncertain about.
We have no bibliographic references for this item. You can help adding them by using this form .
If you know of missing items citing this one, you can help us creating those links by adding the relevant references in the same way as above, for each refering item. If you are a registered author of this item, you may also want to check the "citations" tab in your RePEc Author Service profile, as there may be some citations waiting for confirmation.
For technical questions regarding this item, or to correct its authors, title, abstract, bibliographic or download information, contact: Sonal Shukla or Springer Nature Abstracting and Indexing (email available below). General contact details of provider: http://www.nature.com .
Please note that corrections may take a couple of weeks to filter through
the various RePEc services.